Docusign

(NASDAQ: DOCU · $70.97 ▼ 0.2%) Docusign is a software company focused on electronic signature and agreement management, offering tools that help organisations create, commit and manage agreements. Its central offering is Docusign IAM, short for Intelligent Agreement Management, which the company positions as a way to extract business-critical data trapped inside documents that have historically been disconnected from systems of record. This reflects a broader shift in the category, where e-signature has become a starting point for managing the full contract lifecycle rather than a standalone step.

The product range is organised into preconfigured applications such as IAM Core, IAM for Sales, IAM for Customer Experience and Contract Lifecycle Management, built on individual capabilities that can sometimes be bought separately. These capabilities include eSignature, Agreement Manager, Workflow Builder, Web Forms, Notary, Identify, Payments, Multi-Channel Delivery via SMS or WhatsApp, and an FDA Part 11 Module that supports compliance with 21 CFR Part 11, while a platform service called Iris applies AI to provide real-time insights and automated actions on agreements. In practice, this layered structure lets a buyer begin with basic signing and add automation, analytics or identity checks as needs grow.

Docusign solutions are used by more than a billion people and some 1.9 million customers in over 180 countries, including 95% of Fortune 500 companies. It serves industries ranging from financial services, healthcare and government to real estate and manufacturing, with solutions aimed at sales, HR, legal and procurement teams. Signing is available in 44 languages, and the company lists certifications including ISO 27001, FedRAMP and PCI DSS, credentials that typically matter to buyers in regulated and public-sector settings.